Clin2
NCT06696482Worth exploringNot yet recruiting

Effort and antidepressant study for healthy adults

Effort Based Decision MakingProsocial BehaviorApathy

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests how a common antidepressant (escitalopram) affects motivation and effort in healthy adults. It aims to understand how the drug works in the brain, which could help improve treatments for depression.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
50 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are between 18 and 40 years old.
  • You are right-handed.
  • You have no current or past psychiatric conditions (like depression, anxiety, or ADHD).
  • You are not taking any medications that could interact with the study drug.
  • You have no significant medical conditions (like epilepsy, diabetes, or brain injury).
  • You are not pregnant or planning to become pregnant, and you are not breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07771595Not yet recruiting· Phase 4
How atomoxetine affects motivation in healthy adults

This study tests whether a medication called atomoxetine (commonly used for ADHD) can affect motivation in healthy adults. It involves taking the medication and completing tasks to measure motivation, which could help understand how this drug works.

Oxford
NCT05017311Recruiting· Phase 4
Testing a depression medication plan using symptom predictions

This Phase 4 study tests an “optimized” medication approach for adults with major depressive disorder (unipolar depression) based on how you respond over time. It may help your care team choose treatments more effectively and reduce trial-and-error.

Calgary, Alberta
NCT06412315Recruiting
Brain scan study of emotion and a common antidepressant

This study uses a powerful MRI scanner to look at how a part of the brain called the amygdala responds to emotional tasks, and whether a common antidepressant called citalopram affects that response. It may help researchers understand how these treatments work for mental health conditions.

Oxford, Oxfordshire
NCT06826326Enrolling by invitation· Phase 2
Brain imaging of an antidepressant in teens with autism

This study tests if the antidepressant escitalopram can improve brain function in teenagers with autism. Participants will take the medicine and have brain scans (MRI) to see how it affects brain activity.

Kansas City, Kansas
NCT04623099Recruiting· Phase 4
Personalized escitalopram dosing for anxious teens

This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.

Cincinnati, Ohio
NCT05866575Recruiting
Brain-modeling trial to predict depression treatment response

This trial uses computer modeling based on brain measurements to try to predict which depression treatment will work for you. It may help match you with the most effective option faster by understanding your motivation-related brain patterns.

La Tronche, Isère

Hear when a new Prosocial Behavior trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.